These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. Dong Z; Chai W; Wang W; Zhao L; Fu Z; Cao W; Liu Z Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E222-8. PubMed ID: 23193054 [TBL] [Abstract][Full Text] [Related]
26. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Coggins M; Lindner J; Rattigan S; Jahn L; Fasy E; Kaul S; Barrett E Diabetes; 2001 Dec; 50(12):2682-90. PubMed ID: 11723050 [TBL] [Abstract][Full Text] [Related]
27. Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans. Sauder MA; Liu J; Jahn LA; Fowler DE; Chai W; Liu Z J Clin Endocrinol Metab; 2012 Jul; 97(7):E1208-12. PubMed ID: 22508711 [TBL] [Abstract][Full Text] [Related]
28. Nitric oxide directly promotes vascular endothelial insulin transport. Wang H; Wang AX; Aylor K; Barrett EJ Diabetes; 2013 Dec; 62(12):4030-42. PubMed ID: 23863813 [TBL] [Abstract][Full Text] [Related]
29. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats. Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611 [TBL] [Abstract][Full Text] [Related]
30. Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT. Fortepiani LA; Ruiz MC; Passardi F; Bentley MD; Garcia-Estan J; Ritman EL; Romero JC Am J Physiol Renal Physiol; 2003 Nov; 285(5):F852-60. PubMed ID: 12837684 [TBL] [Abstract][Full Text] [Related]
31. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker. Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518 [TBL] [Abstract][Full Text] [Related]
32. Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats. Ishizawa K; Yoshizumi M; Tsuchiya K; Takishita E; Nakaya Y; Kishi K; Ebina Y; Houchi H; Minakuchi K; Tamaki T Eur J Pharmacol; 2001 Nov; 430(2-3):359-67. PubMed ID: 11711055 [TBL] [Abstract][Full Text] [Related]
33. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850 [TBL] [Abstract][Full Text] [Related]
34. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats. Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342 [TBL] [Abstract][Full Text] [Related]
35. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Roy D; Perreault M; Marette A Am J Physiol; 1998 Apr; 274(4):E692-9. PubMed ID: 9575831 [TBL] [Abstract][Full Text] [Related]
36. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats. Hsieh PS J Hypertens; 2005 Dec; 23(12):2209-17. PubMed ID: 16269963 [TBL] [Abstract][Full Text] [Related]
37. ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance. Huisamen B; Pêrel SJ; Friedrich SO; Salie R; Strijdom H; Lochner A Mol Cell Biochem; 2011 Mar; 349(1-2):21-31. PubMed ID: 21153603 [TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Li G; Barrett EJ; Barrett MO; Cao W; Liu Z Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186 [TBL] [Abstract][Full Text] [Related]
39. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179. Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287 [TBL] [Abstract][Full Text] [Related]
40. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage. Helle F; Iversen BM; Chatziantoniou C Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]